Literature DB >> 8892477

Radiosurgery, cost-effectiveness, gold standards, the scientific method, cavalier cowboys, and the cost of hope.

P W Sperduto, W A Hall.   

Abstract

Mesh:

Year:  1996        PMID: 8892477     DOI: 10.1016/s0360-3016(96)00347-1

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  3 in total

1.  Use of stereotactic radiosurgery for brain metastases from non-small cell lung cancer in the United States.

Authors:  Lia M Halasz; Jane C Weeks; Bridget A Neville; Nathan Taback; Rinaa S Punglia
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-10-09       Impact factor: 7.038

2.  Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA).

Authors:  Paul W Sperduto; Wen Jiang; Paul D Brown; Steve Braunstein; Penny Sneed; Daniel A Wattson; Helen A Shih; Ananta Bangdiwala; Ryan Shanley; Natalie A Lockney; Kathryn Beal; Emil Lou; Thomas Amatruda; William A Sperduto; John P Kirkpatrick; Norman Yeh; Laurie E Gaspar; Jason K Molitoris; Laura Masucci; David Roberge; James Yu; Veronica Chiang; Minesh Mehta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-11-15       Impact factor: 7.038

3.  Increased survival with the combination of stereotactic radiosurgery and gefitinib for non-small cell lung cancer brain metastasis patients: a nationwide study in Taiwan.

Authors:  Ching-Heng Lin; Kuo-Hsuan Hsu; Shih-Ni Chang; Hsi-Kai Tsou; Jason Sheehan; Meei-Ling Sheu; Hung-Chuan Pan
Journal:  Radiat Oncol       Date:  2015-06-06       Impact factor: 3.481

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.